Published in Vaccine on June 01, 2003
Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev (2009) 4.55
Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production. Blood (2005) 1.22
Immunological control of fish diseases. Mar Biotechnol (NY) (2010) 1.15
Airway delivery of an adenovirus-based Ebola virus vaccine bypasses existing immunity to homologous adenovirus in nonhuman primates. J Virol (2013) 1.08
Innate immune evasion mediated by the Ambystoma tigrinum virus eukaryotic translation initiation factor 2alpha homologue. J Virol (2011) 1.05
Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol (2005) 1.05
The innate pulmonary granuloma: characterization and demonstration of dendritic cell recruitment and function. Am J Pathol (2004) 1.03
The CovS/CovR acid response regulator is required for intracellular survival of group B Streptococcus in macrophages. Infect Immun (2012) 0.98
rPbPga1 from Paracoccidioides brasiliensis Activates Mast Cells and Macrophages via NFkB. PLoS Negl Trop Dis (2015) 0.80
Chronic inflammation as a manifestation of defects in immunoregulatory networks: implications for novel therapies based on microbial products. Inflammopharmacology (2009) 0.78
Biological effects of listeriolysin O: implications for vaccination. Biomed Res Int (2015) 0.77
Antibodies against Marinobacter algicola and Salmonella typhimurium flagellins do not cross-neutralize TLR5 activation. PLoS One (2012) 0.76
Modeling long-term host cell-Giardia lamblia interactions in an in vitro co-culture system. PLoS One (2013) 0.76
Transcriptomic analysis of Crassostrea sikamea × Crassostrea angulata hybrids in response to low salinity stress. PLoS One (2017) 0.75
A tug-of-war between the host and the pathogen generates strategic hotspots for the development of novel therapeutic interventions against infectious diseases. Virulence (2015) 0.75
Susceptibility of Helicobacter pylori to metronidazole. Am J Gastroenterol (2003) 1.98
Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig Dis Sci (2004) 1.51
Intestinal tuberculosis. Curr Opin Infect Dis (2009) 1.47
A comparison amongst three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic. Intern Emerg Med (2010) 1.46
Diagnosis, prevention, and management of delirium: summary of NICE guidance. BMJ (2010) 1.36
Management of rheumatoid arthritis: summary of NICE guidance. BMJ (2009) 1.26
Inflammatory bowel disease: is the intestine a Trojan horse? Sci Prog (2002) 1.22
Diagnosis of Helicobacter pylori: invasive and non-invasive tests. Best Pract Res Clin Gastroenterol (2007) 1.19
Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis. J Infect Dis (2006) 1.11
Precise role of H pylori in duodenal ulceration. World J Gastroenterol (2006) 1.11
Helicobacter: a paradigm shift in peptic ulcer disease and more? Sci Prog (2002) 1.09
Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol (2005) 1.05
Does Helicobacter pylori really cause duodenal ulcers? No. BMJ (2009) 1.05
Widespread occurrence of Mycobacterium tuberculosis DNA from 18th-19th century Hungarians. Am J Phys Anthropol (2003) 0.95
Helicobacter pylori and gastric cancer: neither friend nor foe. Gastroenterology (2007) 0.94
High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy. J Gastrointestin Liver Dis (2012) 0.92
Morphology of segmented filamentous bacteria and their patterns of contact with the follicle-associated epithelium of the mouse terminal ileum: implications for the relationship with the immune system. Gut Microbes (2011) 0.89
Controversies in the Helicobacter pylori/duodenal ulcer story. Trans R Soc Trop Med Hyg (2008) 0.83
Cholera-like enterotoxins and Regulatory T cells. Toxins (Basel) (2010) 0.82
Presence of Helicobacter pylori in betel chewers and non betel chewers with and without oral cancers. BMC Oral Health (2009) 0.82
Actual concept of "probiotics": is it more functional to science or business? World J Gastroenterol (2013) 0.82
A human domain antibody and Lewis b glycoconjugate that inhibit binding of Helicobacter pylori to Lewis b receptor and adhesion to human gastric epithelium. J Infect Dis (2009) 0.81
Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori. J Antimicrob Chemother (2003) 0.80
Helicobacter pylori virulence factors in duodenal ulceration: A primary cause or a secondary infection causing chronicity. World J Gastroenterol (2006) 0.80
Comparison of image analysis software packages in the assessment of adhesion of microorganisms to mucosal epithelium using confocal laser scanning microscopy. J Microbiol Methods (2005) 0.79
Use of a single biopsy specimen for diagnosing Helicobacter pylori infection by culture and two different PCR methods: report from Cuba. Trop Gastroenterol (2010) 0.77
Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanoma. J Exp Ther Oncol (2003) 0.77
Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics. Adv Nutr (2011) 0.77
Value of information in the osteoarthritis setting: cost effectiveness of COX-2 selective inhibitors, traditional NSAIDs and proton pump inhibitors. Pharmacoeconomics (2011) 0.77
Tumour burden and interleukin-2 dose affect the interaction between low-dose total body irradiation and interleukin 2. Eur J Cancer (2004) 0.77
Clinical presentation and risk factors of inflammatory bowel disease in Sri Lanka. Trop Gastroenterol (2011) 0.76
Helicobacter pylori: current status and future prospects. Sci Prog (2004) 0.75
Meeting the needs of the pay-at-the-pump generation. Health Manag Technol (2002) 0.75
Role of Helicobacter pylori infection in the thyroid diseases. J Gastrointestin Liver Dis (2013) 0.75
Colonization by Helicobacter pylori of leprosy patients in Spain: immunomodulation to low molecular weight antigens of H. pylori. Mem Inst Oswaldo Cruz (2010) 0.75